Total Payments
$120,151
2024 Payments
$16,152
Companies
15
Transactions
67
Medicare Patients
3,108
Medicare Billing
$171,119
Payment Breakdown by Category
Consulting$116,479 (96.9%)
Research$1,375 (1.1%)
Food & Beverage$1,105 (0.9%)
Other$710.75 (0.6%)
Travel$479.07 (0.4%)
Education$2.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $116,479 | 43 | 96.9% |
| Unspecified | $1,375 | 2 | 1.1% |
| Food and Beverage | $1,105 | 18 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $710.75 | 1 | 0.6% |
| Travel and Lodging | $479.07 | 2 | 0.4% |
| Education | $2.77 | 1 | 0.0% |
Payments by Type
General
$118,776
65 transactions
Research
$1,375
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $61,313 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $24,334 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,710 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $6,293 | 13 | $0 (2019) |
| Genentech USA, Inc. | $4,771 | 2 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $4,129 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $3,000 | 1 | $0 (2022) |
| Genentech, Inc. | $2,485 | 4 | $0 (2022) |
| Roche Diagnostics Corporation | $2,425 | 1 | $0 (2024) |
| Janssen Global Services, LLC | $1,760 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,152 | 10 | AstraZeneca UK Limited ($11,390) |
| 2023 | $15,239 | 7 | AstraZeneca UK Limited ($11,193) |
| 2022 | $36,019 | 13 | AstraZeneca UK Limited ($26,563) |
| 2021 | $18,451 | 7 | AstraZeneca UK Limited ($12,168) |
| 2020 | $16,893 | 7 | AstraZeneca Pharmaceuticals LP ($15,133) |
| 2019 | $2,992 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($1,554) |
| 2018 | $6,576 | 7 | Genentech USA, Inc. ($4,750) |
| 2017 | $7,829 | 12 | E.R. Squibb & Sons, L.L.C. ($4,829) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,630.00 | General |
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,512.50 | General |
| 11/06/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $5,750.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $605.00 | General |
| 09/08/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $73.83 | General |
| Category: Oncology | ||||||
| 09/07/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 07/25/2024 | Janssen Scientific Affairs, LLC | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $145.88 | General |
| Category: Oncology | ||||||
| 07/18/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,210.00 | General |
| 05/29/2024 | Roche Diagnostics Corporation | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| Category: None | ||||||
| 04/04/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 12/26/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $605.00 | General |
| 12/15/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,815.00 | General |
| 12/06/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $6,050.00 | General |
| 07/13/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,327.50 | General |
| 05/31/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 02/25/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: BioOncology | ||||||
| 12/19/2022 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $10,890.00 | General |
| 10/06/2022 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,327.50 | General |
| 09/03/2022 | AstraZeneca UK Limited | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $710.75 | General |
| 08/06/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $85.84 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2022 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 04/26/2022 | Genentech, Inc. | TECENTRIQ (Biological) | Consulting Fee | Cash or cash equivalent | $2,260.00 | General |
| Category: BioOncology | ||||||
| 03/31/2022 | Takeda Pharmaceuticals U.S.A., Inc. | EXKIVITY (Drug) | Consulting Fee | Cash or cash equivalent | $2,860.00 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2022 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $4,235.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE II, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ATEZOLIZUMAB AS NEOADJUVANT AND ADJUVANT THERAPY IN PATIENTS WITH STAGE IB, II, IIIA RESECTABLE AND UNTREATED NON-SMALL CELL LUNG CANCER NSCLC | F. Hoffmann-La Roche AG | $1,375 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 600 | 986 | $152,320 | $28,541 |
| 2022 | 15 | 472 | 754 | $111,360 | $21,982 |
| 2021 | 17 | 944 | 1,605 | $403,059 | $51,332 |
| 2020 | 15 | 1,092 | 2,134 | $528,609 | $69,264 |
Total Patients
3,108
Total Services
5,479
Medicare Billing
$171,119
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 157 | 312 | $56,160 | $9,361 | 16.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 71 | 227 | $19,295 | $5,261 | 27.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 30 | 45 | $18,225 | $3,043 | 16.7% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 75 | 80 | $16,000 | $2,733 | 17.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 76 | 86 | $13,330 | $2,454 | 18.4% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 16 | 16 | $9,600 | $1,902 | 19.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 11 | 19 | $4,465 | $968.22 | 21.7% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 24 | 24 | $2,160 | $936.48 | 43.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 23 | 39 | $4,485 | $760.90 | 17.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 30 | 45 | $3,150 | $435.02 | 13.8% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 24 | 29 | $1,450 | $285.09 | 19.7% |
| 88381 | Preparation of specimen, manual | Facility | 2023 | 11 | 11 | $2,145 | $213.29 | 9.9% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 52 | 53 | $1,855 | $187.69 | 10.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 107 | 198 | $33,360 | $5,963 | 17.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 48 | 183 | $15,669 | $4,287 | 27.4% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 12 | 20 | $11,244 | $2,361 | 21.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 17 | 28 | $11,046 | $1,939 | 17.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 55 | 61 | $9,533 | $1,764 | 18.5% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 44 | 48 | $8,858 | $1,658 | 18.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2022 | 34 | 48 | $5,212 | $977.58 | 18.8% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2022 | 19 | 19 | $4,750 | $661.42 | 13.9% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 16 | 16 | $2,070 | $614.50 | 29.7% |
| 88369 | Microscopic genetic analysis of tissue, manual, each additional procedure | Facility | 2022 | 19 | 21 | $1,995 | $570.77 | 28.6% |
| 88291 | Interpretation and report of genetic testing | Facility | 2022 | 12 | 12 | $1,380 | $343.98 | 24.9% |
| 88381 | Preparation of specimen, manual | Facility | 2022 | 14 | 14 | $2,616 | $288.83 | 11.0% |
About Sanja Dacic, MD,PHD
Sanja Dacic, MD,PHD is a Anatomic Pathology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497727002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sanja Dacic, MD,PHD has received a total of $120,151 in payments from pharmaceutical and medical device companies, with $16,152 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($116,479).
As a Medicare-enrolled provider, Dacic has provided services to 3,108 Medicare beneficiaries, totaling 5,479 services with total Medicare billing of $171,119. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Specialist
- Location New Haven, CT
- Active Since 02/07/2006
- Last Updated 04/07/2022
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1497727002
Products in Payments
- TAGRISSO (Drug) $24,327
- EXKIVITY (Drug) $6,710
- OPDIVO (Biological) $4,829
- Avastin (Biological) $4,750
- TECENTRIQ (Biological) $3,859
- Vitrakvi (Drug) $2,554
- IMFINZI (Biological) $2,420
- Non-Covered $1,575
- RYBREVANT (Drug) $219.71
- LIBTAYO (Biological) $85.84
- Tecentriq (Biological) $21.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New Haven
David Rimm, Md, MD
Anatomic Pathology — Payments: $909,236
Anatomic Pathology $909,236
Dr. Sihem Khelifa, M.d, M.D
Anatomic Pathology — Payments: $151,148
Anatomic Pathology $151,148
Pei Hui, Md, MD
Anatomic Pathology — Payments: $76,330
Anatomic Pathology $76,330
Mr. Demetrios Braddock, Md, MD
Anatomic Pathology — Payments: $68,859
Anatomic Pathology $68,859
Dhanpat Jain, Md, MD
Anatomic Pathology — Payments: $22,884
Anatomic Pathology $22,884
Carlo Bifulco, Md, MD
Anatomic Pathology — Payments: $18,942
Anatomic Pathology $18,942